Literature DB >> 15640422

Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes.

M E Tushuizen1, M Diamant, R J Heine.   

Abstract

The worldwide prevalence of type 2 diabetes mellitus has reached epidemic proportions. The so-called traditional risk factors cannot fully explain the excessive cardiovascular disease risk of type 2 diabetic patients. Numerous studies indicate that postprandial metabolic derangements, most notably hyperglycaemia and hypertriglyceridaemia, which are exaggerated and prolonged in type 2 diabetes, are important cardiovascular disease risk factors since they induce oxidative stress and endothelial dysfunctions. This review discusses the current evidence showing that postprandial dysmetabolism may indeed constitute an important cardiovascular disease risk factor as well as the mechanisms underlying this association. Finally, some possible therapeutic options and recommendations for future research are discussed.

Entities:  

Mesh:

Year:  2005        PMID: 15640422      PMCID: PMC1743184          DOI: 10.1136/pgmj.2004.020511

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  58 in total

Review 1.  Postprandial lipoprotein metabolism and atherosclerosis.

Authors:  F Karpe
Journal:  J Intern Med       Date:  1999-10       Impact factor: 8.989

2.  A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction.

Authors:  M J Stampfer; R M Krauss; J Ma; P J Blanche; L G Holl; F M Sacks; C H Hennekens
Journal:  JAMA       Date:  1996-09-18       Impact factor: 56.272

3.  Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes.

Authors:  S Teno; Y Uto; H Nagashima; Y Endoh; Y Iwamoto; Y Omori; T Takizawa
Journal:  Diabetes Care       Date:  2000-09       Impact factor: 19.112

4.  Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer.

Authors:  L Heinemann; W Klappoth; K Rave; B Hompesch; R Linkeschowa; T Heise
Journal:  Diabetes Care       Date:  2000-09       Impact factor: 19.112

5.  Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease.

Authors:  N Mero; R Malmström; G Steiner; M R Taskinen; M Syvänne
Journal:  Atherosclerosis       Date:  2000-05       Impact factor: 5.162

Review 6.  Atherosclerosis.

Authors:  A J Lusis
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

Review 7.  Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects.

Authors:  A Ceriello
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

8.  Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM.

Authors:  J Jeppesen; M Y Zhou; Y D Chen; G M Reaven
Journal:  Diabetes Care       Date:  1994-10       Impact factor: 19.112

9.  Postprandial lipoproteins and progression of coronary atherosclerosis.

Authors:  F Karpe; G Steiner; K Uffelman; T Olivecrona; A Hamsten
Journal:  Atherosclerosis       Date:  1994-03       Impact factor: 5.162

10.  Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress.

Authors:  A Ceriello; R Giacomello; G Stel; E Motz; C Taboga; L Tonutti; M Pirisi; E Falleti; E Bartoli
Journal:  Diabetes       Date:  1995-08       Impact factor: 9.461

View more
  22 in total

Review 1.  Impact of postprandial glycaemia on health and prevention of disease.

Authors:  E E Blaak; J-M Antoine; D Benton; I Björck; L Bozzetto; F Brouns; M Diamant; L Dye; T Hulshof; J J Holst; D J Lamport; M Laville; C L Lawton; A Meheust; A Nilson; S Normand; A A Rivellese; S Theis; S S Torekov; S Vinoy
Journal:  Obes Rev       Date:  2012-07-11       Impact factor: 9.213

Review 2.  The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD.

Authors:  Michaela Diamant; Maarten E Tushuizen
Journal:  Curr Diab Rep       Date:  2006-08       Impact factor: 4.810

3.  The role of postprandial hyperglycemia and hyperlipidemia in CVD risk.

Authors:  Robert J Heine
Journal:  Curr Diab Rep       Date:  2006-02       Impact factor: 4.810

4.  The metabolic syndrome: what's in a name?

Authors:  Glenn Matfin
Journal:  Ther Adv Endocrinol Metab       Date:  2010-04       Impact factor: 3.565

Review 5.  Diabetes and cardiovascular disease: focus on glucagon-like peptide-1 based therapies.

Authors:  Paul Stranges; Ujjaini Khanderia
Journal:  Ther Adv Drug Saf       Date:  2012-08

Review 6.  Challenges in developing drugs for the metabolic syndrome.

Authors:  Glenn Matfin
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

7.  A comparative study on the fasting and the postprandial dyslipidaemia in type 2 diabetes mellitus.

Authors:  Lokhande Suryabhan L; Iyer Chandrashekhar M; Shinde Ratnendra R; Nandedkar Prerna D
Journal:  J Clin Diagn Res       Date:  2013-03-09

Review 8.  The Diagnosis and Treatment of Hypertriglyceridemia.

Authors:  Klaus G Parhofer; Ulrich Laufs
Journal:  Dtsch Arztebl Int       Date:  2019-12-06       Impact factor: 5.594

Review 9.  Hypertriglyceridemia: its etiology, effects and treatment.

Authors:  George Yuan; Khalid Z Al-Shali; Robert A Hegele
Journal:  CMAJ       Date:  2007-04-10       Impact factor: 8.262

10.  Effect of Soybean and Soybean Koji on Obesity and Dyslipidemia in Rats Fed a High-Fat Diet: A Comparative Study.

Authors:  Sihoon Park; Jae-Joon Lee; Hye-Won Shin; Sunyoon Jung; Jung-Heun Ha
Journal:  Int J Environ Res Public Health       Date:  2021-06-04       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.